查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1638753

2024年至2032年牛結核病診斷市場機會、成長動力、產業趨勢分析與預測

Bovine Tuberculosis Diagnosis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球牛結核病診斷市場達到7.955億美元，預計2024年至2032年複合年成長率為7.5%。

嚴格的政府法規和積極主動的舉措是市場的關鍵驅動力，世界各地的當局都實施了更嚴格的檢測方案來遏制牛結核病的傳播。此外，乳製品消費量的增加正在推動對更健康牛群的需求，使得全面的牛結核病診斷對於保障公眾健康至關重要。

市場分為兩大類：產品和服務。該產品領域佔最大佔有率，預計在預測期內複合年成長率為 7.4%。這種主導地位歸因於廣泛的診斷工具，例如 PCR 檢測、結核菌素皮膚測試和 ELISA 試劑盒。持續的研究和開發工作正在增強這些工具的有效性。此外，即時檢測的創新和診斷實驗室自動化的整合正在進一步加速該領域的成長。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 7.955 億美元
預測值 15億美元
複合年成長率 7.5%

市場也依樣本類型細分，包括血液、鼻拭子、組織樣本等。 2023 年，血液樣本佔據了最大的市場佔有率，達到 55.4%。血清學檢測可檢查血液中的特定抗體或抗原，可提供可靠且快速的結果，使其成為早期檢測和及時干預的首選方法。血液採樣的非侵入性及其簡單性也有助於其在常規監測和檢測項目中的廣泛應用。

預計 2024 年至 2032 年，美國牛結核病診斷產業將以 6.9% 的複合年成長率成長。該市場的成長是由診斷技術的進步和監測能力的增強所推動的。 PCR和新一代定序等分子檢測方法的引入提高了牲畜結核病檢測的診斷準確性和效率。採用先進的診斷工具和全面的篩檢計劃，可以更輕鬆地及早發現疾病，確保更好地控制和管理疫情。這些技術進步和加強的監測實踐使美國成為全球牛結核病診斷市場的關鍵參與者。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 牛結核病率上升
      • 診斷技術的研究與開發
      • 政府支持和舉措
      • 乳製品消費增加
    • 產業陷阱與挑戰
      • 缺乏標準化的診斷方案
  • 成長潛力分析
  • 未來市場趨勢
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

  • 主要趨勢
  • 產品
  • 服務
    • 結核菌素皮膚試
      • 比較子宮頸測試 (CCT)
      • 單次皮內測試 (SIT)
      • 單子宮頸測試 (SCT) 或尾部（尾部）折疊測試 (CFT)
    • 基於血液的化驗測試
      • γ 干擾素 (IFN-Y) 測定
      • 酵素連結免疫吸附測定法 (ELISA)
      • 其他基於血液的化驗測試
    • 分子診斷測試

第 6 章：市場估計與預測：按樣本類型，2021 - 2032 年

  • 主要趨勢
  • 血液樣本
  • 鼻拭子
  • 組織樣本
  • 其他樣品

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 獸醫院
  • 科學研究機構
  • 獸醫診斷實驗室
  • 畜牧農場和牧場

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 9 章：公司簡介

  • Bio-Rad Laboratories
  • Chembio Diagnostics
  • Enfer
  • IDEXX Laboratories
  • IDVet
  • LIONEX
  • PBD Biotech
  • QIAGEN
  • Thermo Fisher Scientific
  • ZENDAL
簡介目錄
Product Code: 12141

The Global Bovine Tuberculosis Diagnosis Market reached USD 795.5 million in 2023 and is projected to expand at 7.5% CAGR from 2024 to 2032. This growth is largely driven by the increasing prevalence of bovine tuberculosis worldwide and significant innovations in diagnostic technology.

Strict government regulations and proactive initiatives are key drivers for the market, with authorities worldwide implementing more rigorous testing protocols to curb the spread of bovine tuberculosis. Furthermore, the rising consumption of dairy products is boosting the demand for healthier cattle populations, making comprehensive bovine tuberculosis diagnostics essential for safeguarding public health.

The market is divided into two main categories: products and services. The product segment holds the largest share and is expected to grow at a CAGR of 7.4% during the forecast period. This dominance is attributed to a wide range of diagnostic tools, such as PCR assays, tuberculin skin tests, and ELISA kits. Continuous research and development efforts are enhancing the effectiveness of these tools. Moreover, innovations in point-of-care testing and the integration of automation in diagnostic laboratories are further accelerating growth in this segment.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$795.5 Million
Forecast Value$1.5 Billion
CAGR7.5%

The market is also segmented by sample type, which includes blood, nasal swabs, tissue samples, and others. Blood samples held the largest market share at 55.4% in 2023. This dominance is due to the effectiveness of blood samples in detecting Mycobacterium bovis, the causative agent of bovine tuberculosis. Serological tests, which examine blood for specific antibodies or antigens, provide reliable and quick results, making them the preferred method for early detection and timely intervention. The non-invasive nature of blood sampling, combined with its simplicity, also contributes to its widespread use in routine surveillance and testing programs.

The U.S. bovine tuberculosis diagnosis industry is expected to grow at a CAGR of 6.9% from 2024-2032. The growth in this market is driven by advancements in diagnostic techniques and enhanced surveillance capabilities. The introduction of molecular testing methods, such as PCR and next-generation sequencing, has improved diagnostic accuracy and efficiency in detecting tuberculosis in livestock. The adoption of advanced diagnostic tools and comprehensive screening programs has made it easier to detect the disease early, ensuring better control and management of outbreaks. These technological advancements and strengthened surveillance practices position the U.S. as a key player in the global bovine tuberculosis diagnosis market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of bovine tuberculosis
      • 3.2.1.2 Research and development in diagnostic techniques
      • 3.2.1.3 Government support and initiatives
      • 3.2.1.4 Increasing consumption of dairy products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Lack of standardized diagnostic protocols
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Technology landscape
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Product
  • 5.3 Services
    • 5.3.1 Tuberculin skin test
      • 5.3.1.1 Comparative Cervical Test (CCT)
      • 5.3.1.2 Single Intradermal Test (SIT)
      • 5.3.1.3 Single Cervical Test (SCT) or Caudal (tail) Fold Test (CFT)
    • 5.3.2 Blood-based assay test
      • 5.3.2.1 Gamma Interferon (IFN-Y) assay
      • 5.3.2.2 Enzyme-linked Immunosorbent Assay (ELISA)
      • 5.3.2.3 Other blood-based assay test
    • 5.3.3 Molecular diagnostics tests

Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Blood sample
  • 6.3 Nasal swabs
  • 6.4 Tissue sample
  • 6.5 Other samples

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Veterinary hospitals
  • 7.3 Research institutes
  • 7.4 Veterinary diagnostic laboratories
  • 7.5 Livestock farms and ranches

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Bio-Rad Laboratories
  • 9.2 Chembio Diagnostics
  • 9.3 Enfer
  • 9.4 IDEXX Laboratories
  • 9.5 IDVet
  • 9.6 LIONEX
  • 9.7 PBD Biotech
  • 9.8 QIAGEN
  • 9.9 Thermo Fisher Scientific
  • 9.10 ZENDAL